DiaMedica Therapeutics Inc. DMAC
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- +3.64%
- 1 year
- +14.27%
Held by funds
38 US ETFs and mutual funds hold DMAC · largest positions
- IWM 0.01% of fund $8.04M
- NJM 0.01% of fund $4.47M
- VXF 0.00% of fund $3.34M
- IWO 0.02% of fund $2.99M
- FSSNX 0.01% of fund $2.54M
- VTWO 0.01% of fund $1.99M
- NLO 0.01% of fund $1.58M
- FSMAX 0.00% of fund $1.22M
- IWC 0.08% of fund $963.90K
- MDSKX 0.01% of fund $629.14K
- IJE 0.04% of fund $501.17K
- VTWG 0.02% of fund $375.62K
- FNCMX 0.00% of fund $275.49K
- FECGX 0.01% of fund $232.31K
- SMMD 0.00% of fund $177.97K
- RSSL 0.01% of fund $151.98K
- FZIPX 0.00% of fund $107.38K
- IWMW* MX 0.01% of fund $94.95K
- BSMAX 0.01% of fund $91.16K
- BASMX 0.00% of fund $48.96K
Ownership
- Institutions 31.6%
- Insiders 26.2%
- Public and other holders 42.2%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Cooperman, Leon G. | 3.54% | 1,511,739 | 8.13M | Sep 29, 2024 |
| Vanguard Group Inc | 2.45% | 1,049,029 | 5.64M | Sep 29, 2024 |
| First Manhattan Co. LLC | 1.96% | 839,081 | 4.51M | Sep 29, 2024 |
| Paragon Associates & Paragon Associates Ii Joint Venture | 1.13% | 482,614 | 2.59M | Sep 29, 2024 |
| Bleichroeder LP | 0.89% | 382,317 | 2.05M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.72% | 306,958 | 1.65M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.75% | 747,198 | 4.02M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.59% | 253,733 | 1.36M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.35% | 149,057 | 801.18K | Oct 30, 2024 |
| Jacob Discovery Fd | 0.27% | 114,730 | 616.67K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.13% | 55,116 | 296.25K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.11% | 48,734 | 261.94K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs DMAC, and what each was last paid
Dietrich John Pauls, President, Chief Executive Officer & DirectorAverage age 63
| Name | Title | Pay | Age |
|---|---|---|---|
| Dietrich John Pauls | President, Chief Executive Officer & Director | $1.07M | 55 |
| Julie Krop | Chief Medical Officer | $676K | 60 |
| Scott Kellen | Chief Financial Officer & Corporate Secretary | $610K | 61 |
| Dominic R. Cundari | Chief Commercial Officer | — | 75 |
| Ambarish Shah | Chief Technology Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GIUFFRE RANDALL MICHAEL | Director | Stock Award(Grant) | Jan 1, 2024 | 411,194 |
| KELLEN SCOTT | Chief Financial Officer | Purchase | Jun 22, 2023 | 32,290 |
| KUNTZ RICHARD P | Director | Stock Award(Grant) | Jan 1, 2024 | 14,285 |
| PARSONS JAMES T CPA | Director | Stock Award(Grant) | Jan 1, 2024 | 59,937 |
| PAULS DIETRICH JOHN | Chief Executive Officer | Purchase | Jun 22, 2023 | 68,591 |
| PILNIK RICHARD D | Director | Stock Award(Grant) | Jan 1, 2024 | 278,602 |
